# Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD

> **NCT07494474** · — · NOT_YET_RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 834 (estimated)

## Conditions studied

- Autoimmune Thyroid Disease

## Interventions

- **DIAGNOSTIC_TEST:** Islet autoantibodies tested

## Key facts

- **NCT ID:** NCT07494474
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-31
- **Primary completion:** 2027-11-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 834 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07494474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07494474, "Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07494474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*